Drug Type Small molecule drug |
Synonyms ENB 005, ENB-005 |
Target |
Mechanism ETB antagonists(Endothelin receptor type B antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization ENB Therapeutics, Inc.Startup |
Active Organization ENB Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Brain metastases | Preclinical | US | ENB Therapeutics, Inc.Startup | - |
Glioblastoma | Preclinical | US | ENB Therapeutics, Inc.Startup | - |
Lymphoma | Preclinical | US | ENB Therapeutics, Inc.Startup | - |